This week’s issue of the New England Journal of Medicine features an article that highlights an unprecedented analysis of the nation’s childhood head injuries. The study, authored by physicians at UC Davis School of Medicine and Washington University School of Medicine, analyzed more than 43,000 children who were evaluated for head trauma at 25 emergency departments around the United States.
The only drug currently approved for treatment of stroke’s crippling effects shows promise, when administered as a nasal spray, to help heal similar damage in less severe forms of traumatic brain injury.
In the first examination of its kind, researchers Ye Xiong, Ph.D, Zhongwu Liu, Ph.D., and Michael Chopp, Ph.D., Scientific Director of the Henry Ford Neuroscience Institute, found in animal studies that the brain’s limited ability to repair itself after trauma can be enhanced when treated with the drug tPA, or tissue plasminogen activator.
The potential for doctors to measure damaging "brain tsunamis” in injured patients without opening the skull has moved a step closer to reality, thanks to pioneering research at the University of Cincinnati (UC) Neuroscience Institute.
DARPA and Stanford Brain Imaging Collaboration helps to bring a new CLARITY to the world of Neuroscience
Thanks to a 100 million dollar grant through the White House Brain Mapping Project to the NIH, NSF, and DARPA (Defense Advanced Research Projects Agency), a dynamically new approach to how we view the brain has arisen: the CLARITY Brain Imaging Technique. With this technique, scientists are hoping to map brain connections on a large scale, visualizing how every single neuron is fired and interconnected with the other ones in the system.
Among Patients with TBI, Maintaining Higher Hemoglobin Concentration or Receiving Hormone EPO Does Not Improve Neurological Outcomes
Study finds cognitive performance can be improved in teens months, years after traumatic brain injury
Each year, more than 17 million Americans suffer a mild traumatic brain injury (mTBI), more commonly known as a concussion, of which approximately 15 percent suffer persistent symptoms beyond three months.
Assessing outcomes and recovery time after concussion can be very subjective. Typically, physicians must rely on patient cooperation to assess injury severity.